Rothstein M A, Richards O C, Amin C, Ehrenfeld E
Department of Cellular, Viral and Molecular Biology, University of Utah Medical Center, Salt Lake City 84132.
Virology. 1988 Jun;164(2):301-8. doi: 10.1016/0042-6822(88)90542-9.
Plasmids have been constructed that contain DNA sequences that direct the expression of the poliovirus RNA-dependent RNA polymerase, in the form of recombinant fusion proteins. Inclusion of an additional gene for the poliovirus protease results in cleavage of the fusion protein to yield a 52-kDa, enzymatically active, polymerase protein, apparently identical to the functional enzyme isolated from virus-infected HeLa cells. A large amount of polymerase protein accumulates as particulate or insoluble material in bacteria, and this protein has little or no activity. However, significant amounts of soluble, active enzyme are recovered, such that the resulting specific activity of crude bacterial extracts is greater than that obtained from virus-infected HeLa cells. Purification of the enzyme from Escherichia coli is readily accomplished, and yields a preparation that will copy poliovirion RNA as template, in the presence of oligo(U) primer. The availability of cloned DNA sequences encoding catalytically active RNA polymerase will allow genetic manipulations to initiate structure-function studies of this enzyme.
已经构建了质粒,其包含以重组融合蛋白形式指导脊髓灰质炎病毒RNA依赖性RNA聚合酶表达的DNA序列。包含脊髓灰质炎病毒蛋白酶的另一个基因会导致融合蛋白的切割,从而产生一种52 kDa、具有酶活性的聚合酶蛋白,显然与从病毒感染的HeLa细胞中分离出的功能酶相同。大量的聚合酶蛋白以颗粒状或不溶性物质的形式在细菌中积累,并且这种蛋白几乎没有或没有活性。然而,回收了大量的可溶性活性酶,使得粗细菌提取物的比活性高于从病毒感染的HeLa细胞中获得的比活性。从大肠杆菌中纯化该酶很容易完成,并得到一种制剂,该制剂在寡聚(U)引物存在下,将脊髓灰质炎病毒粒子RNA作为模板进行复制。编码具有催化活性的RNA聚合酶的克隆DNA序列的可用性将允许进行基因操作以启动对该酶的结构-功能研究。